Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07227779Phase 2Not Yet Recruiting

B-PaLMZ for TB Meningitis

Role: collaborator

NCT02417636Not ApplicableCompleted

Sharing HIV/AIDS Responsibilities and Efforts

Role: lead

NCT02514707Unknown

Outcomes of HIV Infected Individuals After Ten Years on Antiretroviral Treatment

Role: lead

NCT02507921Unknown

Resistance in HIV+ in North and South

Role: lead

NCT02421302Not ApplicableUnknown

The Pediatric HIV Nutrition Study in Uganda

Role: lead

NCT01802736Not ApplicableUnknown

Alcohol Use and Risky Sexual Behaviors Among HIV Infected Subjects in Kampala Uganda

Role: collaborator

All 6 trials loaded